Beverly A. Heinz

3.2k total citations
43 papers, 1.2k citations indexed

About

Beverly A. Heinz is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Epidemiology. According to data from OpenAlex, Beverly A. Heinz has authored 43 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 15 papers in Cellular and Molecular Neuroscience and 11 papers in Epidemiology. Recurrent topics in Beverly A. Heinz's work include Neuroscience and Neuropharmacology Research (11 papers), Receptor Mechanisms and Signaling (11 papers) and Viral Infections and Immunology Research (8 papers). Beverly A. Heinz is often cited by papers focused on Neuroscience and Neuropharmacology Research (11 papers), Receptor Mechanisms and Signaling (11 papers) and Viral Infections and Immunology Research (8 papers). Beverly A. Heinz collaborates with scholars based in United States, Spain and United Kingdom. Beverly A. Heinz's co-authors include Chafiq Hamdouchi, Joseph M. Gruber, Lori Vance, Jesús de Blas, Q. May Wang, Allen D. Kline, C. Cheng Kao, Daryl F. Venable, Kevin L. McKnight and Lisa M. Broad and has published in prestigious journals such as Journal of Molecular Biology, Journal of Virology and The FASEB Journal.

In The Last Decade

Beverly A. Heinz

41 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beverly A. Heinz United States 19 519 395 244 203 178 43 1.2k
Ethel C. Garnier‐Amblard United States 12 552 1.1× 356 0.9× 154 0.6× 70 0.3× 137 0.8× 13 1.2k
Thomas M. Graczyk United States 8 564 1.1× 55 0.1× 430 1.8× 49 0.2× 124 0.7× 12 904
Ian Tietjen United States 19 629 1.2× 105 0.3× 147 0.6× 15 0.1× 146 0.8× 58 1.2k
Jeffery A. Williams United States 18 572 1.1× 172 0.4× 388 1.6× 106 0.5× 290 1.6× 40 2.2k
Lars Kuerschner Germany 23 1.6k 3.0× 184 0.5× 68 0.3× 24 0.1× 205 1.2× 30 2.3k
Rocco D. Gogliotti United States 19 669 1.3× 181 0.5× 229 0.9× 17 0.1× 87 0.5× 31 1.1k
Abigail Wolfe United States 19 1.6k 3.0× 451 1.1× 133 0.5× 77 0.4× 382 2.1× 24 3.4k
François‐Xavier Cantrelle France 23 929 1.8× 86 0.2× 178 0.7× 34 0.2× 43 0.2× 71 1.4k
Luigi De Colibus United Kingdom 13 676 1.3× 188 0.5× 166 0.7× 7 0.0× 126 0.7× 19 1.2k
Daryl F. Venable United States 14 330 0.6× 95 0.2× 269 1.1× 89 0.4× 67 0.4× 20 571

Countries citing papers authored by Beverly A. Heinz

Since Specialization
Citations

This map shows the geographic impact of Beverly A. Heinz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beverly A. Heinz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beverly A. Heinz more than expected).

Fields of papers citing papers by Beverly A. Heinz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beverly A. Heinz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beverly A. Heinz. The network helps show where Beverly A. Heinz may publish in the future.

Co-authorship network of co-authors of Beverly A. Heinz

This figure shows the co-authorship network connecting the top 25 collaborators of Beverly A. Heinz. A scholar is included among the top collaborators of Beverly A. Heinz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beverly A. Heinz. Beverly A. Heinz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xushan, Zhaohui Yang, Mah Lee Ng, et al.. (2025). Development of high-throughput analytical methods for characterization and quantitation of rAAV genome integrity. Molecular Therapy — Methods & Clinical Development. 33(4). 101579–101579.
2.
Thompson, Karen, Chiara Zanato, Sergio Dall’Angelo, et al.. (2023). The atypical ‘hippocampal’ glutamate receptor coupled to phospholipase D that controls stretch‐sensitivity in primary mechanosensory nerve endings is homomeric purely metabotropic GluK2. Experimental Physiology. 109(1). 81–99. 12 indexed citations
3.
Wang, Xushan, Beverly A. Heinz, Yuewei Qian, et al.. (2018). Intracellular Binding Site for a Positive Allosteric Modulator of the Dopamine D1 Receptor. Molecular Pharmacology. 94(4). 1232–1245. 26 indexed citations
4.
Felder, Christian C., Douglas A. Schober, Yuan Tu, et al.. (2017). Translational Pharmacology of the Metabotropic Glutamate 2 Receptor–Preferring Agonist LY2812223 in the Animal and Human Brain. Journal of Pharmacology and Experimental Therapeutics. 361(1). 190–197. 5 indexed citations
5.
Heinz, Beverly A., et al.. (2015). Phospho-ERK Assays. Europe PMC (PubMed Central). 1 indexed citations
6.
Witkin, Jeffrey M., Linda Thompson, Chunjin Ding, et al.. (2013). Further Evaluation of the Neuropharmacological Determinants of the Antidepressant-Like Effects of Curcumin. CNS & Neurological Disorders - Drug Targets. 12(4). 498–505. 14 indexed citations
7.
8.
Heinz, Beverly A., et al.. (2012). IP-3/IP-1 Assays. 1 indexed citations
9.
10.
Zwart, Ruud, Anna L. Carbone, Mirko Moroni, et al.. (2008). Sazetidine-A Is a Potent and Selective Agonist at Native and Recombinant α4β2 Nicotinic Acetylcholine Receptors. Molecular Pharmacology. 73(6). 1838–1843. 96 indexed citations
11.
Heinz, Beverly A., et al.. (2004). P4 cap modified tetrapeptidyl α-ketoamides as potent HCV NS3 protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(16). 4333–4338. 13 indexed citations
12.
Colacino, Joseph M. & Beverly A. Heinz. (2004). Hepatitis Prevention and Treatment. Birkhäuser Basel eBooks. 9 indexed citations
13.
Chen, Shu‐Hui, Frantz Victor, Nancy Snyder, et al.. (2003). Synthesis and evaluation of tripeptidyl α-Ketoamides as human rhinovirus 3C protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(20). 3531–3536. 16 indexed citations
14.
Cook, James A., et al.. (2003). Demonstrating the intrinsic ion channel activity of virally encoded proteins. FEBS Letters. 552(1). 61–67. 23 indexed citations
15.
Victor, Frantz, Robert B. Johnson, John I. Glass, et al.. (2003). Discovery of a novel bicycloproline P2 bearing peptidyl α-ketoamide LY514962 as HCV protease inhibitor. Bioorganic & Medicinal Chemistry Letters. 14(1). 251–256. 38 indexed citations
16.
McKnight, Kevin L. & Beverly A. Heinz. (2003). RNA as a Target for Developing Antivirals. Antiviral chemistry & chemotherapy. 14(2). 61–73. 27 indexed citations
17.
Wang, Q. May & Beverly A. Heinz. (2000). Recent advances in prevention and treatment of hepatitis C virus infections. Birkhäuser Basel eBooks. 55. 1–32. 11 indexed citations
18.
Hamdouchi, Chafiq, Jesús Ezquerra, Juan A. Vega, et al.. (1999). Short synthesis and anti-rhinoviral activity of imidazo[1,2-a]pyridines: The effect of acyl groups at 3-position. Bioorganic & Medicinal Chemistry Letters. 9(10). 1391–1394. 32 indexed citations
19.
20.
Badger, John, Sriram Krishnaswamy, Marcia J. Kremer, et al.. (1989). Three-dimensional structures of drug-resistant mutants of human rhinovirus 14. Journal of Molecular Biology. 207(1). 163–174. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ethel C. Garnier‐Amblard Breakdown of academic impact, for papers by Thomas M. Graczyk Breakdown of academic impact, for papers by Ian Tietjen Breakdown of academic impact, for papers by Jeffery A. Williams Breakdown of academic impact, for papers by Lars Kuerschner Breakdown of academic impact, for papers by Rocco D. Gogliotti Breakdown of academic impact, for papers by Abigail Wolfe Breakdown of academic impact, for papers by François‐Xavier Cantrelle Breakdown of academic impact, for papers by Luigi De Colibus Breakdown of academic impact, for papers by Daryl F. Venable
Rankless by CCL
2026